Insider · CIK 0001721664

Laumas Sandeep

Reports to the SEC for 5 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001721664

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	UNCYUnicycive Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+47.9K sh	—	—	47,941
2026-05-14	UNCYUnicycive Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+84.2K sh	—	—	84,200
2026-05-14	UNCYUnicycive Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+42.1K sh	—	—	126,300
2026-05-14	UNCYUnicycive Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+84.2K sh	—	—	84,200
2026-05-14	UNCYUnicycive Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+42.1K sh	—	—	126,300
2026-01-09	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2025-09-10	TILInstil Bio, Inc.M Exercise/Conversion	CFO and CBO	MExercise/Conversion	+17K sh	$11.60	+$197K	17,000
2025-09-10	TILInstil Bio, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CFO and CBO	MExercise/Conversion	−13K sh	—	—	30,000
2025-09-10	TILInstil Bio, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CFO and CBO	MExercise/Conversion	−17K sh	—	—	17,000
2025-09-10	TILInstil Bio, Inc.S Sale	CFO and CBO	SSale	−12.5K sh	$23.88	−$298K	0
2025-09-10	TILInstil Bio, Inc.S Sale	CFO and CBO	SSale	−17.5K sh	$23.04	−$404K	12,461
2025-09-10	TILInstil Bio, Inc.M Exercise/Conversion	CFO and CBO	MExercise/Conversion	+13K sh	$12.68	+$165K	30,000
2025-07-28	UNCYUnicycive Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+21.2K sh	—	—	41,286
2025-04-25	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+44.9K sh	—	—	44,851
2024-09-18	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+45K sh	—	—	45,000
2024-06-10	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2024-02-10	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+80K sh	—	—	80,000
2023-09-05	UNCYUnicycive Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+189K sh	—	—	200,864
2023-06-26	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2023-01-08	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+415K sh	—	—	415,000
2022-05-19	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2022-03-04	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+234K sh	—	—	234,000
2022-03-04	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+234K sh	$8.62	+$2.02M	234,000
2021-06-11	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.5K sh	—	—	14,500
2021-05-11	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+200K sh	—	—	200,000
2021-03-18	TILInstil Bio, Inc. · Employee Stock Option (right to buy)A Award	CFO and CBO	AAward	+240K sh	—	—	240,000
2020-07-06	9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2020-06-30	9 METERS BIOPHARMA, INC.Series A Convertible Preferred StockC Conversion	Director	CConversion	−424 sh	—	—	0
2020-06-30	9 METERS BIOPHARMA, INC.C Conversion	Director	CConversion	+42.4K sh	—	—	60,400
2020-05-21	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-05-04	9 METERS BIOPHARMA, INC.Series A Convertible Preferred StockP Purchase	Director	PPurchase	+424 sh	—	—	42,400
2020-05-04	9 METERS BIOPHARMA, INC.Series A Convertible Preferred WarrantP Purchase	Director	PPurchase	+424 sh	—	—	42,400
2020-04-24	9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+389K sh	—	—	389,294
2019-08-20	9 METERS BIOPHARMA, INC.Stock Option (Right to Buy)A Award	Director	AAward	+400K sh	—	—	400,000
2019-06-28	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+4,000 sh	$1.15	+$4,600	18,000
2019-06-13	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+409 sh	$1.21	+$494.89	13,409
2019-06-13	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+591 sh	$1.22	+$721.02	14,000
2019-05-23	BTAIBioXcel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.7K sh	—	—	14,700
2019-05-22	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+5,000 sh	$1.38	+$6,900	13,000
2018-11-30	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+1,000 sh	$2.64	+$2,640	6,000
2018-11-30	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+1,000 sh	$2.62	+$2,620	7,000
2018-11-30	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+1,000 sh	$2.63	+$2,630	8,000
2018-11-29	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+2,000 sh	$2.56	+$5,120	5,000
2018-11-29	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+1,000 sh	$2.55	+$2,550	3,000
2018-09-07	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+500 sh	$6.10	+$3,050	2,000
2018-08-30	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+500 sh	$5.24	+$2,620	750
2018-08-28	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+95 sh	$5.07	+$481.65	595
2018-08-28	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+250 sh	$4.88	+$1,220	500
2018-08-28	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	+405 sh	$5.08	+$2,057.4	1,000
2018-08-28	9 METERS BIOPHARMA, INC.P Purchase	Director	PPurchase	0 sh	$4.90	$0	250

Recent filings

Accepted (ET)
Jul 284/A
Laumas Sandeep0001213900-26-082270
SEC(opens sec.gov)
Jun 154/A
Laumas Sandeep0001213900-26-068920
SEC(opens sec.gov)
May 184
Laumas Sandeep0001213900-26-058662
SEC(opens sec.gov)
Jan 124
Laumas Sandeep0001104659-26-002981
SEC(opens sec.gov)
Sep 124
Laumas Sandeep0001789769-25-000087
SEC(opens sec.gov)
Jul 304
Laumas Sandeep0001213900-25-069305
SEC(opens sec.gov)
Apr 284
Laumas Sandeep0001789769-25-000041
SEC(opens sec.gov)
Sep 234
Laumas Sandeep0001789769-24-000095
SEC(opens sec.gov)
Jun 114
Laumas Sandeep0001104659-24-070517
SEC(opens sec.gov)
Feb 134
Laumas Sandeep0001789769-24-000025
SEC(opens sec.gov)
Sep 74
Laumas Sandeep0001213900-23-075014
SEC(opens sec.gov)
Jun 284
Laumas Sandeep0001104659-23-075866
SEC(opens sec.gov)
Jan 204
Laumas Sandeep0001789769-23-000008
SEC(opens sec.gov)

Companies

Address

C/O UNICYCIVE THERAPEUTICS, INC. 1975 W. EL CAMINO REAL, SUITE 204

MOUNTAIN VIEW, CA, 94040